Shennon Biotechnologies raises $12M in financing for its precision immunotherapy pipeline and appoints Cyril Konto, M.D., as Chief Executive Officer.
Amount Raised
$12 Million
Round Type
Venture
Description
Shennon Biotechnologies has successfully raised $12 million in financing. The funds will be utilized to support the development of its precision immunotherapy pipeline. Additionally, Cyril Konto, M.D., has been appointed as the new Chief Executive Officer. This move is expected to bolster the company's leadership as it progresses in the biotechnology field.
Quick answer
Shennon Biotechnologies raised $12 Million in a funding round, dated September 14, 2026. Shennon Biotechnologies is based in San Francisco, California, United States.
- How much did Shennon Biotechnologies raise?
- Shennon Biotechnologies raised $12 Million in a funding round on September 14, 2026.
- What does Shennon Biotechnologies do?
- ShennonBio has developed a proprietary platform that can profile millions of immune cells functionally at the single cell level at unprecedented throughput and accuracy, which resolves a key bottleneck in immunotherapy.
- Where is Shennon Biotechnologies based and how big is it?
- Shennon Biotechnologies is based in San Francisco, California, United States. Fundz records about 17 employees.
- Who are the decision-makers at Shennon Biotechnologies?
- Fundz holds 1 contact at Shennon Biotechnologies, including the Founder/CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Shennon Biotechnologies that raised within 45 days of this round, from Fundz verified event records.
- VUSE XR raised $1.3M (Pre-Seed) on October 29, 2026.
- Opentrons Labworks raised $40M (Series E) on October 29, 2026.
- Sonocare Lab raised an undisclosed amount (Seed) on October 29, 2026.
- Quantum Universal raised $109M on October 29, 2026.
- StimCardio raised $30M (Series A) on October 29, 2026.
- Happy Health raised $75M on October 29, 2026.
Who to call at Shennon Biotechnologies, and when
A new round usually means Shennon Biotechnologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Shennon Biotechnologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Shennon Biotechnologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Shennon Biotechnologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Shennon Biotechnologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Shennon Biotechnologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.